Related Experiment Video
Updated: Sep 6, 2025

10:13
Microfluidic Platform for Measuring Neutrophil Chemotaxis from Unprocessed Whole Blood
Published on: June 3, 2014
11.4K
3D printed microfluidic Coulter counter for blood cell analysis
Jiasheng Yan1, Chuang Wang1, Yusheng Fu1
1University of Electronic Science and Technology of China, Chengdu, China. uestc_gjc@163.com.
The Analyst
|June 28, 2022
Summary
A novel 3D microfluidic printing kit offers a disposable solution for accurate Coulter cell count analysis, eliminating clogging issues and cross-contamination risks. This innovation enhances biological sample analysis, particularly for white blood cells.
Area of Science:
- Biomedical Engineering
- Microfluidics
- Analytical Chemistry
Background:
- Coulter counters are essential for cell analysis but prone to clogging with reduced orifice sizes.
- Traditional methods for managing clogs are inconvenient and costly, hindering widespread application.
Purpose of the Study:
- To present a 3D microfluidic printing-based single-use kit for accurate Coulter cell count analysis.
- To address and overcome the clogging issue in microfluidic Coulter counters.
- To develop a disposable, hygienic, and cost-effective solution for cell analysis.
Main Methods:
- Utilizing 3D microfluidic printing to create a disposable analysis kit with an integrated 'gem hole'.
- Designing the kit to be independent of the main analysis instrument, enabling a separate detection module.
- Employing a solid water flow system to prevent clogging without traditional methods.
Main Results:
- The novel design effectively eliminates clogging issues associated with traditional Coulter counters.
- The disposable kit ensures hygiene and prevents cross-infection during biological sample analysis.
- The independent module design simplifies the analysis process and enhances convenience.
Conclusions:
- The 3D printed single-use kit provides a hygienic, clog-free, and accurate method for Coulter cell counting.
- This approach offers a significant advancement for point-of-care (POCT) detection and routine laboratory analysis.
- Mass production potential indicates a future where cost is no longer a barrier to advanced cell analysis.

